コンテンツへスキップ
Merck
  • Identification of the active form of endothelial lipase, a homodimer in a head-to-tail conformation.

Identification of the active form of endothelial lipase, a homodimer in a head-to-tail conformation.

The Journal of biological chemistry (2009-07-02)
Nathalie Griffon, Weijin Jin, Thomas J Petty, John Millar, Karen O Badellino, Jeffery G Saven, Dawn H Marchadier, Ellis S Kempner, Jeffrey Billheimer, Jane M Glick, Daniel J Rader
要旨

Endothelial lipase (EL) is a member of a subfamily of lipases that act on triglycerides and phospholipids in plasma lipoproteins, which also includes lipoprotein lipase and hepatic lipase. EL has a tropism for high density lipoprotein, and its level of phospholipase activity is similar to its level of triglyceride lipase activity. Inhibition or loss-of-function of EL in mice results in an increase in high density lipoprotein cholesterol, making it a potential therapeutic target. Although hepatic lipase and lipoprotein lipase have been shown to function as homodimers, the active form of EL is not known. In these studies, the size and conformation of the active form of EL were determined. Immunoprecipitation experiments suggested oligomerization. Ultracentrifugation experiments showed that the active form of EL had a molecular weight higher than the molecular weight of a simple monomer but less than a dimer. A construct encoding a covalent head-to-tail homodimer of EL (EL-EL) was expressed and had similar lipolytic activity to EL. The functional molecular weights determined by radiation inactivation were similar for EL and the covalent homodimer EL-EL. We previously showed that EL could be cleaved by proprotein convertases, such as PC5, resulting in loss of activity. In cells overexpressing PC5, the covalent homodimeric EL-EL appeared to be more stable, with reduced cleavage and conserved lipolytic activity. A comparative model obtained using other lipase structures suggests a structure for the head-to-tail EL homodimer that is consistent with the experimental findings. These data confirm the hypothesis that EL is active as a homodimer in head-to-tail conformation.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
リパーゼ Candida rugosa由来, Type VII, ≥700 unit/mg solid
Sigma-Aldrich
リパーゼ ブタ膵臓由来, Type II, ≥125 units/mg protein (using olive oil (30 min incubation)), 30-90 units/mg protein (using triacetin)
Sigma-Aldrich
リパーゼ・アクリル樹脂 from Candida antarctica, ≥5,000 U/g, recombinant, expressed in Aspergillus niger
Sigma-Aldrich
リパーゼB, Candida antarctica由来, 組換え体 from Aspergillus oryzae, powder, beige, ~9 U/mg
Sigma-Aldrich
リパーゼ ブタ膵臓由来, Type VI-S, ≥20,000 units/mg protein, lyophilized powder
Sigma-Aldrich
リパーゼ from Aspergillus niger, powder (fine), ~200 U/g
Sigma-Aldrich
リパーゼ Candida rugosa由来, lyophilized powder, ≥40,000 units/mg protein
Sigma-Aldrich
リパーゼ Candida sp.(カンジダ属)由来, recombinant, expressed in Aspergillus niger
Sigma-Aldrich
Lipase immobilized from Candida antarctica, beads, slightly brown, >2 U/mg
Sigma-Aldrich
リパーゼ from Rhizomucor miehei, ≥20,000 U/g
Sigma-Aldrich
リパーゼ Pseudomonas cepacia由来, powder, light beige, ≥30 U/mg
Sigma-Aldrich
リパーゼ コムギ胚芽由来, Type I, lyophilized powder, 5-15 units/mg solid
Sigma-Aldrich
リパーゼ from Rhizopus oryzae, powder (fine), ~10 U/mg
Sigma-Aldrich
リパーゼ Candida rugosa由来, powder, yellow-brown, ≥2 U/mg
Sigma-Aldrich
リパーゼ Pseudomonassp. (シュードモナス)由来, Type XIII, lyophilized powder, ≥15 units/mg solid
Sigma-Aldrich
リパーゼ from Aspergillus oryzae, lyophilized, powder, white, ~50 U/mg
Sigma-Aldrich
リパーゼ Candida rugosa由来, lyophilized, powder (fine), 15-25 U/mg
Sigma-Aldrich
リパーゼ from Mucor miehei, lyophilized powder, ≥4,000 units/mg solid (using olive oil)
Sigma-Aldrich
リパーゼ from Rhizopus niveus, powder (fine), ≥1.5 U/mg
Sigma-Aldrich
Lipase A Candida antarctica, recombinant from Aspergillus oryzae, powder, beige, ~2 U/mg
Sigma-Aldrich
リパーゼ from Mucor miehei, powder, slightly brown, ~1 U/mg
Sigma-Aldrich
リパーゼ from Mucor javanicus, lyophilized powder, ≥300 units/mg solid (using olive oil)